Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings Routine +

Charlotte's Web Reports Shareholder Meeting Voting Results

Charlotte's Web Secures BAT Partnership, But Dilution and Cash Burn Weigh on Sentiment

Executive Summary
  • Charlotte's Web Holdings announced shareholder approval of a significant transaction with British American Tobacco (BAT) involving debenture amendment and equity investment.
  • Shareholder vote results showed 94% support for the transaction with 60.12% turnout, indicating strong management alignment despite dilution concerns.
  • BAT will receive approximately 109,944,042 common shares representing a 40.6% ownership stake in the combined company post-closing.
  • Closing is anticipated on or about May 28, 2026, subject to TSX approval and customary conditions.
  • The transaction involves converting C$75.3 million principal convertible debenture plus accrued interest into equity, alongside a concurrent $10 million private placement equity investment.
  • Director elections were approved with high margins (91%-96% for), including new director M. Borgia Walker replacing Jonathan Atwood.
Material Impact
  • The news confirms the execution of the previously announced March 2026 financing deal, removing regulatory and shareholder approval uncertainty.
  • While positive for balance sheet stability, the market has already priced in this transaction as evidenced by the stock rally to $1.29 in February followed by a correction to current levels.
  • The 40% ownership stake for BAT represents significant dilution for existing shareholders, which may limit upside potential despite debt elimination.
  • The removal of C$75 million debt and ~$3 million annual interest costs is material for solvency but does not immediately address operational profitability issues.
  • Given the prior "Material - Positive" rating on the initial announcement in March, this voting result is an expected milestone rather than a new catalyst.
CWEB · Price
Company Overview
  • Charlotte's Web Holdings operates in the hemp-derived CBD, THC, and wellness supplement space with a focus on consumer products and pharmaceutical development.
  • Flagship consumer brand includes Brightside gummies (THC/CBN), sleep support lines, and functional mushroom offerings.
  • Strategic pivot towards medical channel via participation in the CMMI Medicare pilot program for senior oncology patients.
  • Pharmaceutical subsidiary DeFloria is developing AJA001 oral solution for autism spectrum disorder irritability, currently in Phase 2 trial preparation.
  • Manufacturing capabilities include internalized gummy production at Louisville, CO facility with NSF cGMP audit zero findings.
Read the original news release →

More from CHARLOTTE'S WEB HOLDINGS, INC.